1 1 1 1 1 1 1 BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 1 no 0 11
DU145 human du145 D DU DU1 DU14 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 - 1 11
κB: κB: κb: κ κB κB: κB: BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 1 : 1 1
New insights new N Ne New New BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 2 . 1 11
Mori K. mori M Mo Mor Mori BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 1 2 .,,*,.,,.,,.,,.,,*,., 21 11
1. INSERM, 1. 1 1. 1. 1. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 .,,,- 5 11
2. Université 2. 2 2. 2. 2. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 .,, 3 11
Résorption Osseuse résorption R Ré Rés Réso BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 ,,,- 4 11
France France france F Fr Fra Fran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 1 7 no 0 11
Correspondence and correspondence C Co Cor Corr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 : 1 11
Dr. D. dr. D Dr Dr. Dr. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 8 ...;, 5 11
Physiopathologie de physiopathologie P Ph Phy Phys BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 . 1 11
Faculté de faculté F Fa Fac Facu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 9 ,,,, 4 11
Tel: +33 tel: T Te Tel Tel: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 10 : 1 11
Fax: +33 fax: F Fa Fax Fax: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 11 : 1 11
e-mail: dominique.heymann@univ-nantes.fr e-mail: e e- e-m e-ma BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 11 -:.-..-.. 9 11
2 2 2 2 2 2 2 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 1 no 0 11
Abstract Abstract abstract A Ab Abs Abst BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 no 0 11
Prostate cancer prostate P Pr Pro Pros BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 no 0 11
represent the represent r re rep repr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 , 1 11
significant morbidity significant s si sig sign BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 ., 2 11
understanding the understanding u un und unde BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 11
molecular level molecular m mo mol mole BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 . 1 11
Activator of activator A Ac Act Acti BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 4 -()//() 7 11
bone metabolism bone b bo bon bone BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 5 , 1 11
metastases. In metastases. m me met meta BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 .,, 3 11
and PC3 and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 .,(, 4 11
100ng/ml) treatment 100ng/ml) 1 10 100 100n BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 /)/,. 5 11
administration also administration a ad adm admi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 7 . 1 11
human OPG human h hu hum huma BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 ()(/), 6 11
association of association a as ass asso BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 -. 2 11
had no had h ha had had BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 , 1 11
RANKL-induced cell rankl-induced R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 10 -. 2 11
osteoclastogenesis of osteoclastogenesis o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 10 ., 2 11
DU145 cells du145 D DU DU1 DU14 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 11 ()-- 4 11
pre-osteoblasts through pre-osteoblasts p pr pre pre- BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 12 -/. 3 11
3 3 3 3 3 3 3 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 1 no 0 11
This stimulation this T Th Thi This BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 - 1 11
expression that expression e ex exp expr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 /, 2 11
facilitating prostate facilitating f fa fac faci BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 4 . 1 11
factor that factor f fa fac fact BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 no 0 11
RANK-positive prostate rank-positive R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 7 -., 3 11
evidence that evidence e ev evi evid BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 - 1 11
the level the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 ,- 2 11
cells in cells c ce cel cell BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 12 . 1 11
4 4 4 4 4 4 4 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 1 no 0 11
Key words: key K Ke Key Key BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 1 2 :,,,, 5 11
5 5 5 5 5 5 5 BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 1 no 0 11
Introduction Introduction introduction I In Int Intr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 no 0 11
Prostate cancer prostate P Pr Pro Pros BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 no 0 11
the major the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 [,]. 4 11
are observed are a ar are are BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 no 0 11
complication of complication c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 , 1 11
mortality [1, mortality m mo mor mort BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 3 [,]., 5 11
prostate cancer prostate p pr pro pros BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 4 no 0 11
bone volume bone b bo bon bone BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 5 []., 4 11
function [4-9]; function f fu fun func BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 5 [-];. 5 11
Therefore, understanding therefore, T Th The Ther BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 6 , 1 11
bone at bone b bo bon bone BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 1 7 no 0 11
should lead should s sh sho shou BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 7 . 1 11
Receptor activator receptor R Re Rec Rece BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 -()//() 7 11
represent the represent r re rep repr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 , 1 11
including prostate including i in inc incl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 9 [,]. 4 11
mature osteoclasts mature m ma mat matu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 - 1 11
stimulating factor stimulating s st sti stim BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 10 (-)[,]. 7 11
pre-osteoblastic cells, pre-osteoblastic p pr pre pre- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 11 -, 2 11
osteoclast precursors osteoclast o os ost oste BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 12 [,]. 4 11
6 6 6 6 6 6 6 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 1 no 0 11
receptor and receptor r re rec rece BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 1 , 1 11
RANKL to rankl R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 []. 3 11
of the of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 //, 3 11
cancer bone cancer c ca can canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 2 []., 4 11
RANKL-RANK interaction rankl-rank R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 3 -[-]. 5 11
Furthermore, an furthermore, F Fu Fur Furt BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 , 1 11
bone metastases bone b bo bon bone BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 4 [,].-- 6 11
ligand (TRAIL), ligand l li lig liga BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 (),- 4 11
thus represents thus t th thu thus BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 []. 3 11
osteoclast/osteoclast precursors osteoclast/osteoclast o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 / 1 11
osteoclast differentiation, osteoclast o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 ,[,,,]., 8 11
demonstrated the demonstrated d de dem demo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 no 0 11
bone, including bone, b bo bon bone BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 ,,-[,]. 7 11
new insights new n ne new new BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 []. 3 11
Indeed, it indeed, I In Ind Inde BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 , 1 11
(RANKL) or (rankl) ( (R (RA (RAN BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 10 ()(-,) 6 11
osteoclast differentiation osteoclast o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 []., 4 11
growth factors growth g gr gro grow BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 (--, 4 11
Transforming Growth transforming T Tr Tra Tran BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 12 -,) 3 11
7 7 7 7 7 7 7 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 1 no 0 11
cell proliferation cell c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 []. 3 11
in bone in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 1 . 1 11
Previous studies previous P Pr Pre Prev BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 [] 2 11
recently RANK recently r re rec rece BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 [,], 4 11
elucidate the elucidate e el elu eluc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 no 0 11
therapeutic relevance therapeutic t th the ther BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 //, 3 11
human prostate human h hu hum huma BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 11
Materials and materials M Ma Mat Mate BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 11
Cell culture cell C Ce Cel Cell BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 no 0 11
Huma n huma H Hu Hum Huma BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 6 () 2 11
American Type american A Am Ame Amer BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 7 (,).-,- 7 11
pre-osteoblast cell pre-osteoblast p pr pre pre- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 -(,). 5 11
and MC3T3-E1 and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 -''()( 6 11
Whittaker, Verviers, whittaker, W Wh Whi Whit BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 10 ,,)(,,), 8 11
respectively supplemented respectively r re res resp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 (,,), 5 11
humidified atmosphere humidified h hu hum humi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 12 (/). 4 11
Characterization of characterization C Ch Cha Char BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 12 no 0 11
8 8 8 8 8 8 8 BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 1 no 0 11
- RNA - - - - - BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 1 -- 2 11
Total RNA total T To Tot Tota BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 1 no 0 11
(Invitrogen) following (invitrogen) ( (I (In (Inv BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 ()'.,() 7 11
transcribed (RT) transcribed t tr tra tran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 ()-(). 6 11
(Promega, Madison, (promega, ( (P (Pr (Pro BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 (,,). 5 11
1.25 U 1.25 1 1. 1.2 1.25 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .(,,) 5 11
downstream primers downstream d do dow down BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 ()() 4 11
[5'-gctaacctcaccttcgag-3' (sense), [5'-gctaacctcaccttcgag-3' [ [5 [5' [5'- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 ['--'(),'--'(-)], 17 11
(hRANK) [5'-ttaagccagtgcttcacggg-3' (hrank) ( (h (hR (hRA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 ()['--'(),'--'(-)], 19 11
human RANKL human h hu hum huma BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ()['--'(),'--' 14 11
(anti-sense)], (anti-sense)], (anti-sense)], ( (a (an (ant BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 (-)], 5 6
human human human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 no 0 3
interleukin interleukin interleukin i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 no 0 5
(hIL)-6 (hIL)-6 (hil)-6 ( (h (hI (hIL BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 ()- 3 3
[5'-aaagaggcactggcagaaaa-3' [5'-aaagaggcactggcagaaaa-3' [5'-aaagaggcactggcagaaaa-3' [ [5 [5' [5'- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 6 ['--' 5 11
(sense), (sense), (sense), ( (s (se (sen BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 6 (), 3 4
5'-aaagctgcgcagaatgagat-3' (anti-sense)], 5'-aaagctgcgcagaatgagat-3' 5 5' 5'- 5'-a BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 '--'(-)],-['--'(), 18 11
5'-gcccagtcaagtgtcaggtg-3' 5'-gcccagtcaagtgtcaggtg-3' 5'-gcccagtcaagtgtcaggtg-3' 5 5' 5'- 5'-g BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 '--' 4 11
(anti-sense)], (anti-sense)], (anti-sense)], ( (a (an (ant BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 (-)], 5 6
human human human h hu hum huma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 8 no 0 3
oncostatin oncostatin oncostatin o on onc onco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 no 0 5
M M m M M M M BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 8 no 0 1
(hOSM) (hOSM) (hosm) ( (h (hO (hOS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 8 () 2 3
[5'-ataggcagctgctcgaaaga-3' (sense), [5'-ataggcagctgctcgaaaga-3' [ [5 [5' [5'- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 8 ['--'(),'--'(-)], 17 11
leukemia leukemia leukemia l le leu leuk BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 4
inhibitory inhibitory inhibitory i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 no 0 4
factor factor factor f fa fac fact BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 9 no 0 3
(hLIF) (hLIF) (hlif) ( (h (hL (hLI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 () 2 3
[5'-accagatcaggagccaactg-3' [5'-accagatcaggagccaactg-3' [5'-accagatcaggagccaactg-3' [ [5 [5' [5'- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 9 ['--' 5 11
(sense), (sense), (sense), ( (s (se (sen BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 9 (), 3 4
5'-gttgacagcccagcttcttc-3' (anti-sense)] 5'-gttgacagcccagcttcttc-3' 5 5' 5'- 5'-g BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 10 '--'(-)]['--'(), 16 11
5'-ttattgctcaatctcgggtggct-3' (anti-sense)]. 5'-ttattgctcaatctcgggtggct-3' 5 5' 5'- 5'-t BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 11 '--'(-)].: 10 11
denaturation for denaturation d de den dena BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 ,(), 4 11
(hOPG) and (hopg) ( (h (hO (hOP BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 12 ()(-,-,,), 10 11
9 9 9 9 9 9 9 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 1 no 0 11
(hRANK), and (hrank), ( (h (hR (hRA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 1 (),. 4 11
increased, a increased, i in inc incr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 1 , 1 11
of the of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 no 0 11
signal determined signal s si sig sign BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 ., 2 11
hRANKL, hOPG, hrankl, h hR hRA hRAN BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 ,,-,,-,, 8 11
respectively. The respectively. r re res resp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 . 1 11
bromide. The bromide. b br bro brom BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 .. 2 11
-Immunocytochemistry -Immunocytochemistry -immunocytochemistry - -I -Im -Imm BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 - 1 11
The analysis the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 11
performed by performed p pe per perf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ., 2 11
cells were cells c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 (,)/, 5 11
centrifuged for centrifuged c ce cen cent BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 (, 2 11
Thermo Electron thermo T Th The Ther BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 ,). 3 11
stained by stained s st sta stai BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 . 1 11
in distilled in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 10 ,- 2 11
antibody (1:5 antibody a an ant anti BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 (:,,,), 7 11
biotin-labelled secondary biotin-labelled b bi bio biot BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 11 -(:,., 6 11
Gilbertsville, PA, gilbertsville, G Gi Gil Gilb BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 12 ,,).- 5 11
10 10 10 1 10 10 10 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 1 no 0 11
(Sigma-Aldrich, St. (sigma-aldrich, ( (S (Si (Sig BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 (-,.,,)., 9 11
commercially available commercially c co com comm BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 (,-), 5 11
counterstained with counterstained c co cou coun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 . 1 11
with PBS with w wi wit with BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 . 1 11
Signal transduction signal S Si Sig Sign BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 11
DU145 and du145 D DU DU1 DU14 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 -- 2 11
their respective their t th the thei BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 ., 2 11
their respective their t th the thei BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 4 - 1 11
hours before hours h ho hou hour BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 ,,,,, 5 11
of 100ng/ml of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 /(,.,, 6 11
USA). Both usa). U US USA USA) BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 7 ).-(,,- 7 11
1%, sodium 1%, 1 1% 1%, 1%, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 ,.,,,/, 7 11
10mg/ml, PMSF 10mg/ml, 1 10 10m 10mg BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 /,.). 5 11
bicinchominic acid bicinchominic b bi bic bici BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 9 (,)., 5 11
bovine serum bovine b bo bov bovi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 ()(/ 4 11
diluted in diluted d di dil dilu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 ).() 4 11
determined at determined d de det dete BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 11 no 0 11
a Wallac a a a a a BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 3 12 (,,). 5 11
11 11 11 1 11 11 11 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 1 no 0 11
of proteins of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 -(), 4 11
transferred to transferred t tr tra tran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 1 ()(,,,). 8 11
The levels the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 2 /(/),(/), 9 11
(Ser32) (Cell (ser32) ( (S (Se (Ser BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 ()(,,,),/( 10 11
Signaling Technologies), signaling S Si Sig Sign BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 ),(,,),(-, 10 11
Yvelines, France) yvelines, Y Yv Yve Yvel BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 ,)(,- 5 11
Yvelines, France) yvelines, Y Yv Yve Yvel BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 ,),.,, 6 11
Chemiluminescence Western chemiluminescence C Ch Che Chem BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 (,,). 5 11
Migration analyses migration M Mi Mig Migr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 no 0 11
DU145 and du145 D DU DU1 DU14 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 no 0 11
24-multiwell plate, 24-multiwell 2 24 24- 24-m BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 7 -,. 3 11
At the at A At At At BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 ,( 2 11
and 100ng/ml) and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 /)., 4 11
each confluent each e ea eac each BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 9 , 1 11
hours with hours h ho hou hour BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 (/).(., 7 11
100ng/ml) alone 100ng/ml) 1 10 100 100n BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 /)-(: 5 11
1:5) were 1:5) 1 1: 1:5 1:5) BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 11 :). 3 11
in each in i in in in BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 3 12 ./(,), 6 11
12 12 12 1 12 12 12 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 1 no 0 11
p38 inhibitor p38 p p3 p38 p38 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 (,)-(,) 7 11
(Calbiochem, CA, (calbiochem, ( (C (Ca (Cal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 2 (,,). 5 11
were added were w we wer were BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 2 no 0 11
culture period culture c cu cul cult BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 . 1 11
Time lapse time T Ti Tim Time BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 11
DU145 cells du145 D DU DU1 DU14 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 4 - 1 11
plate, and plate, p pl pla plat BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 ,, 2 11
100ng/ml shRANKL. 100ng/ml 1 10 100 100n BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 /.-(,) 6 11
minutes during minutes m mi min minu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 . 1 11
divisions was divisions d di div divi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 no 0 11
according to according a ac acc acco BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 :/(). 5 11
control DU145 control c co con cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 , 1 11
6-multiwell plate 6-multiwell 6 6- 6-m 6-mu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 9 -(). 4 11
To measure to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 -, 2 11
into three into i in int into BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 11 . 1 11
total invaded total t to tot tota BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 12 . 1 11
Cell proliferation cell C Ce Cel Cell BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 12 no 0 11
13 13 13 1 13 13 13 BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 1 no 0 11
- XTT - - - - - BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 1 - 1 11
DU145 cells du145 D DU DU1 DU14 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 1 - 1 11
plate, and plate, p pl pla plat BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 ,. 2 11
presence of presence p pr pre pres BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 (,,/). 6 11
proliferation was proliferation p pr pro prol BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 ,() 3 11
following to following f fo fol foll BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 '.,, 4 11
reagent were reagent r re rea reag BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 ,., 3 11
450 nm 450 4 45 450 450 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 6 . 1 11
-Trypan blue -trypan - -T -Tr -Try BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 - 1 11
Trypan blue trypan T Tr Try Tryp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 7 . 1 11
into a into i in int into BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 -(/). 5 11
10% FBS 10% 1 10 10% 10% BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 9 /, 2 11
counted at counted c co cou coun BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 10 ,. 2 11
Human prostate human H Hu Hum Huma BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 no 0 11
-Conditioned medium -conditioned - -C -Co -Con BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 10 -() 3 11
DU145 cells du145 D DU DU1 DU14 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 (/)- 4 11
in DMEM in i in in in BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 4 12 ., 2 11
14 14 14 1 14 14 14 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 1 no 0 11
medium was medium m me med medi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 -/. 3 11
After 24 after A Af Aft Afte BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 1 ,() 3 11
minutes and minutes m mi min minu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 2 -.- 3 11
same conditions same s sa sam same BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 3 (). 3 11
-Osteoclastogenesis -Osteoclastogenesis -osteoclastogenesis - -O -Os -Ost BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 3 - 1 11
Osteoclast precursors osteoclast O Os Ost Oste BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 3 --(, 4 11
Le Genest le L Le Le Le BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 4 4 ,)., 4 11
were suspended were w we wer were BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 -()- 4 11
amino acid amino a am ami amin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 ()()/-( 7 11
systems). After systems). s sy sys syst BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 6 ).,-. 5 11
They were they T Th The They BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 7 -(/)- 5 11
FBS and fbs F FB FBS FBS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 /,/ 3 11
M-CSF, with m-csf, M M- M-C M-CS BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 8 -,(/).- 7 11
performed using performed p pe per perf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 -(,,,). 7 11
Half of half H Ha Hal Half BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 10 ., 2 11
tartrate-resistant acid tartrate-resistant t ta tar tart BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 11 -()(-) 6 11
following the following f fo fol foll BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 11 ',- 3 11
multinucleated cells multinucleated m mu mul mult BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 12 (). 3 11
15 15 15 1 15 15 15 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 1 no 0 11
effect through effect e ef eff effe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 -,(/) 5 11
was also was w wa was was BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 1 . 1 11
-Pre-osteoblast cell -pre-osteoblast - -P -Pr -Pre BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 2 -- 2 11
The mouse the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 2 ---(. 5 11
x 10 x x x x x BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 4 3 /) 2 11
or without or o or or or BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 4 /. 2 11
48 hours 48 4 48 48 48 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 4 no 0 11
above. As above. a ab abo abov BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 5 .,- 3 11
(50-500µg/ml, Sigma), (50-500µg/ml, ( (5 (50 (50- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 6 (-/,),.- 8 11
measured by measured m me mea meas BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 6 , 1 11
with cell with w wi wit with BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 []., 4 11
determine which determine d de det dete BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 8 - 1 11
from DU145, from f fr fro from BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 ,.- 3 11
western blot, western w we wes west BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 ,--(/)- 7 11
antibody (10µg/ml) antibody a an ant anti BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 (/)().-(/,) 11 11
negative control. negative n ne neg nega BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 11 .-- 3 11
DU145 according du145 D DU DU1 DU14 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 12 no 0 11
culture period culture c cu cul cult BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 12 . 1 11
16 16 16 1 16 16 16 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 1 no 0 11
-Signal transduction -signal - -S -Si -Sig BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 - 1 11
MC3T3-E1 cells mc3t3-e1 M MC MC3 MC3T BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 -(/)- 5 11
with 10% with w wi wit with BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 .-,- 4 11
DMEM, cultured dmem, D DM DME DMEM BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 3 ,-, 3 11
minutes with minutes m mi min minu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 .-,,, 5 11
the presence the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ., 2 11
prepared as prepared p pr pre prep BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 () 2 11
analyses. The analyses. a an ana anal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 ./(/), 6 11
(Thr180/Tyr182), signal (thr180/tyr182), ( (T (Th (Thr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 7 (/),()(), 9 11
(Tyr705) (Cell (tyr705) ( (T (Ty (Tyr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 ()(),(, 7 11
immunodetection, San immunodetection, i im imm immu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 ,,,)()() 8 11
were determined were w we wer were BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 /(),( 5 11
systems), STAT1, systems), s sy sys syst BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 10 ),,,(,,)( 9 11
Technologies). Technologies). technologies). T Te Tec Tech BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 ). 2 11
-Alkaline Phosphatase -alkaline - -A -Al -Alk BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 11 -() 3 11
Alkaline phosphatase alkaline A Al Alk Alka BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 ()- 3 11
reported [27] reported r re rep repo BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 12 [].,- 5 11
17 17 17 1 17 17 17 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 1 no 0 11
24-multiwell plate 24-multiwell 2 24 24- 24-m BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 -(/) 4 11
cells supplemented cells c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 /(). 4 11
period, cells period, p pe per peri BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 ,-[,,-, 7 11
sodium deoxycholate sodium s so sod sodi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 .,,/,/, 7 11
0.5mM]. ALP 0.5mm]. 0 0. 0.5 0.5m BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 .].(,', 7 11
France) according france) F Fr Fra Fran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 5 )'. 3 11
- Mineralization - - - - - BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 6 - 1 11
Alizarin red-S alizarin A Al Ali Aliz BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 6 - 1 11
previously reported previously p pr pre prev BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 []., 4 11
cultured in cultured c cu cul cult BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 -- 2 11
dexamethasone (Sigma), dexamethasone d de dex dexa BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 (),/()-- 8 11
(Sigma) was (sigma) ( (S (Si (Sig BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 9 ()., 4 11
and then and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 -. 2 11
water and water w wa wat wate BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 10 -(,,,,.) 8 11
for 10 for f fo for for BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 11 ., 2 11
nodes was nodes n no nod node BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 12 . 1 11
Statistical analysis statistical S St Sta Stat BLOCKSTART PAGEEND NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 12 no 0 11
18 18 18 1 18 18 18 BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 1 no 0 11
Represented data represented R Re Rep Repr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 .-' 3 11
U test u U U U U BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 2 .. 2 11
considered statistically considered c co con cons BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 . 1 11
Results Results results R Re Res Resu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 1 1 0 0 0 0 0 5 3 no 0 11
Human prostate human H Hu Hum Huma BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 3 no 0 11
The expression the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 4 // 2 11
DU145 and du145 D DU DU1 DU14 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 5 .- 2 11
lines were lines l li lin line BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 5 ( 1 11
1). We 1). 1 1) 1). 1). BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 ).- 3 11
cross-talks through cross-talks c cr cro cros BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 7 -.- 3 11
and LIF; and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 8 ;-(). 5 11
Immunocytochemical analyses immunocytochemical I Im Imm Immu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 no 0 11
DU145 and du145 D DU DU1 DU14 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 10 ,(). 4 11
RANKL induces rankl R RA RAN RANK BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 11 /, 2 9
κB phosphorylation κb κ κB κB κB BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 11 - 1 11
cancer cells cancer c ca can canc BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 12 no 0 11
19 19 19 1 19 19 19 BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 1 no 0 11
As RANK as A As As As BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 , 1 11
functionality by functionality f fu fun func BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 1 - 1 11
prostate cancer prostate p pr pro pros BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 /. 2 11
3A showed 3a 3 3A 3A 3A BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 /,, 3 11
and 15 and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 3 . 1 11
shRANKL treatment shrankl s sh shR shRA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 (/)/ 4 11
PC3 cells pc3 P PC PC3 PC3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 ; 1 11
cells (Figure cells c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 (). 3 11
pathways in pathways p pa pat path BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 -() 3 11
cells is cells c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 . 1 11
RANKL stimulates rankl R RA RAN RANK BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 7 no 0 11
In a in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 6 7 , 1 11
activity in activity a ac act acti BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 -,. 3 11
showed that showed s sh sho show BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 no 0 11
in the in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 6 9 - 1 11
(Figures 4A, (figures ( (F (Fi (Fig BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 10 (,)./ 5 11
marked effect marked m ma mar mark BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 11 (,), 4 11
with shRANKL with w wi wit with BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 12 ::(-) 5 11
20 20 20 2 20 20 20 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 1 no 0 11
shRANKL-induced cell shrankl-induced s sh shR shRA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 -(,). 5 11
transduction pathways transduction t tr tra tran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 . 1 11
Among the among A Am Amo Amon BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 2 ,,/ 3 11
RANKL-induced cell rankl-induced R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 3 -(,), 5 11
showed no showed s sh sho show BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 (). 3 11
invasion on invasion i in inv inva BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 (, 2 11
compared to compared c co com comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 );., 4 11
analyses were analyses a an ana anal BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 . 1 11
slit time slit s sl sli slit BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 . 1 11
cells were cells c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 7 / 1 11
control group control c co con cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 (....,., 8 11
Figure 4B). figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 9 ). 2 11
RANKL does rankl R RA RAN RANK BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 10 no 0 11
Additional experiments additional A Ad Add Addi BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 10 - 1 11
of DU145 of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 10 -. 2 11
XTT assay xtt X XT XTT XTT BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 11 no 0 11
cell proliferation cell c ce cel cell BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 12 (/). 4 11
21 21 21 2 21 21 21 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 1 no 0 11
absence of absence a ab abs abse BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 no 0 11
assay (50.3% assay a as ass assa BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 (..,.). 7 11
DU145 cells du145 D DU DU1 DU14 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 2 () 2 11
Co-cultures of co-cultures C Co Co- Co-c BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 3 - 1 11
marrow cells marrow m ma mar marr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 . 1 11
We demonstrated we W We We We BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 - 1 11
20% despite 20% 2 20 20% 20% BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 (.)(). 6 11
observed with observed o ob obs obse BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 -- 2 11
not necessary not n no not not BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 . 1 11
osteoclasts was osteoclasts o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 7 - 1 11
mononuclear cells mononuclear m mo mon mono BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 8 .(/) 4 11
same effect same s sa sam same BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 -/ 2 11
treatment (Figure treatment t tr tre trea BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 9 (). 3 11
DU145 effects du145 D DU DU1 DU14 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 9 -- 2 11
-Soluble factor(s) -soluble - -S -So -Sol BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 10 -()- 4 11
When CM when W Wh Whe When BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 11 -, 2 11
up-regulation of up-regulation u up up- up-r BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 11 --(.,). 7 11
22 22 22 2 22 22 22 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 1 no 0 11
CM from cm C CM CM CM BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 - 1 11
proliferation (Figure proliferation p pr pro prol BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 1 ().,-, 6 11
stimulation of stimulation s st sti stim BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 2 - 1 11
dose-dependent manner dose-dependent d do dos dose BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 3 -(). 4 11
produce growth produce p pr pro prod BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ()-. 4 11
neutralizing inhibitors neutralizing n ne neu neut BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 5 ,-- 3 11
DU145-induced MC3T3-E1 du145-induced D DU DU1 DU14 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 5 --(). 5 11
- Conditioned - - - - - BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 6 -/ 2 11
transduction pathways transduction t tr tra tran BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 7 - 1 11
We further we W We We We BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 7 no 0 11
cell-induced stimulation cell-induced c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 8 --.- 4 11
incubated in incubated i in inc incu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 9 ,/ 2 11
phosphorylations were phosphorylations p ph pho phos BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 9 ,(). 4 11
-Conditioned medium -conditioned - -C -Co -Con BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 10 - 1 11
nodule formation nodule n no nod nodu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 11 - 1 11
To see to T To To To BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 11 () 2 11
modulate osteoblast modulate m mo mod modu BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 12 , 1 11
23 23 23 2 23 23 23 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 1 no 0 11
MC3T3-E1 cells. mc3t3-e1 M MC MC3 MC3T BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 1 -. 2 11
mineralized nodule mineralized m mi min mine BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 1 -(). 4 11
These overall these T Th The Thes BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 2 no 0 11
modulate bone modulate m mo mod modu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 - 1 11
proliferation through proliferation p pr pro prol BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 /. 2 11
Discussion Discussion discussion D Di Dis Disc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 no 0 11
The present the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 no 0 11
RANKL-RANK axis rankl-rank R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 4 --., 4 11
demonstrated the demonstrated d de dem demo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 11
prostate cancer prostate p pr pro pros BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 . 1 11
administration promoted administration a ad adm admi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 6 , 1 11
the increased the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 . 1 11
Second, we second, S Se Sec Seco BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 7 ,() 3 11
in bone in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 8 - 1 11
osteoclastogenesis. These osteoclastogenesis. o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 .- 2 11
bone cells bone b bo bon bone BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 9 . 1 11
Because DU145 because B Be Bec Beca BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 no 0 11
PC3 cells pc3 P PC PC3 PC3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 10 (), 3 11
using DU145 using u us usi usin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 11 .; 2 11
model of model m mo mod mode BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 12 no 0 11
24 24 24 2 24 24 24 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 1 no 0 11
established [28]. established e es est esta BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 []., 4 11
to PC3 to t to to to BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 ;- 2 11
using this using u us usi usin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 . 1 11
RANK expressed rank R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 7 2 no 0 11
osteoclast differentiation osteoclast o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 [,,,]. 6 11
type, as type, t ty typ type BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 ,[],[], 7 11
[20], kidney [20], [ [2 [20 [20] BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 [],[][]., 9 11
on tumor on o on on on BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 [][,]., 7 11
reported the reported r re rep repo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 6 -[]. 4 11
RANK-expressing cells, rank-expressing R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 7 -,- 3 11
osteosarcoma cell osteosarcoma o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 7 []., 4 11
osteosarcoma cell osteosarcoma o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 8 (,--) 5 11
some human some s so som some BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 (. 2 11
submitted). In submitted). s su sub subm BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 ).,. 4 11
RANK on rank R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 7 10 (-,,), 6 11
(LNCaP, DU145) (lncap, ( (L (LN (LNC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 10 (,)()[]. 8 11
RANKL-induced RANK-positive rankl-induced R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 11 --,. 4 11
observed RANKL-triggered observed o ob obs obse BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 12 -- 2 11
melanoma cells. melanoma m me mel mela BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 12 . 1 11
25 25 25 2 25 25 25 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 1 no 0 11
The biological the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 1 no 0 11
including ERK including i in inc incl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 /,,[], 6 11
response to response r re res resp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 .,- 3 11
partially mediated partially p pa par part BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 / 1 11
signalling pathways signalling s si sig sign BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 . 1 11
Although both although A Al Alt Alth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 4 no 0 11
at the at a at at at BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 4 ,, 2 11
being able being b be bei bein BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 () 2 11
and/or juxtacrine and/or a an and and/ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 6 /()., 5 11
in this in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 7 ():/ 4 11
other is other o ot oth othe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 7 -. 2 11
on osteoclast/osteoclast on o on on on BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 8 / 1 11
that allows that t th tha that BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 -. 2 11
factors stimulate factors f fa fac fact BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 no 0 11
development in development d de dev deve BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 7 10 []. 3 11
subsequent RANK-positive subsequent s su sub subs BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 11 -., 3 11
expressed on expressed e ex exp expr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 11 no 0 11
propensity for propensity p pr pro prop BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 12 ., 2 11
26 26 26 2 26 26 26 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 1 no 0 11
its overall its i it its its BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 , 1 11
osteolytic lesion osteolytic o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 1 [-]. 4 11
The RANKL/RANK/OPG the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 2 // 2 11
both normal both b bo bot both BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 2 []. 3 11
involvement of involvement i in inv invo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 [-,,]. 6 11
Indeed, it indeed, I In Ind Inde BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 3 ,,()- 5 11
RANKL activity rankl R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 4 [,, 3 11
9]. In 9]. 9 9] 9]. 9]. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ]., 3 11
sRANK-Fc did srank-fc s sR sRA sRAN BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 -., 3 11
et al. et e et et et BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 .-/-- 5 11
non-osseous tissue non-osseous n no non non- BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 7 -()[,]. 7 11
growth inhibition growth g gr gro grow BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 - 1 11
rather than rather r ra rat rath BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 [,]. 4 11
evidence that evidence e ev evi evid BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 9 - 1 11
their migration. their t th the thei BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 10 .-, 3 11
necessary to necessary n ne nec nece BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 10 ., 2 11
osteoclasts/osteoclast precursors osteoclasts/osteoclast o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 11 /, 2 11
cell migration. cell c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 .,-/-- 6 11
inhibition might inhibition i in inh inhi BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 12 - 1 11
27 27 27 2 27 27 27 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 1 no 0 11
by reducing by b by by by BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 -., 3 11
exogenous OPG exogenous e ex exo exog BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 -' 2 11
proliferation or proliferation p pr pro prol BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 ,. 2 11
could be could c co cou coul BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 , 1 11
tumor growth. tumor t tu tum tumo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 . 1 11
Alternatively, we alternatively, A Al Alt Alte BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 3 , 1 11
osteoblast cells. osteoblast o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 4 ., 2 11
demonstrated that demonstrated d de dem demo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ()- 3 11
osteoclastogenesis by osteoclastogenesis o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 .,. 3 11
significantly induce significantly s si sig sign BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 -- 2 11
pathways [5]. pathways p pa pat path BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 []. 3 11
due to due d du due due BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 .,- 3 11
multinucleated osteoclasts multinucleated m mu mul mult BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 8 -- 2 11
using culture using u us usi usin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 . 1 11
(i.e., fluid (i.e., ( (i (i. (i.e BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 9 (..,,,)., 9 11
been reported been b be bee been BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 10 -/ 2 11
resulted in resulted r re res resu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 10 []., 4 11
from DU145 from f fr fro from BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 -- 2 11
1/2 and 1/2 1 1/ 1/2 1/2 BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 12 /- 2 11
28 28 28 2 28 28 28 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 1 no 0 11
differentiation. No differentiation. d di dif diff BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .-- 3 11
proliferation and proliferation p pr pro prol BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 1 .,, 3 11
inhibited MC3T3-E1 inhibited i in inh inhi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 -, 2 11
that DU145 that t th tha that BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 -- 2 11
proliferation. Therefore, proliferation. p pr pro prol BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 .,- 3 11
proliferation promoting proliferation p pr pro prol BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ().- 4 11
proliferation assay proliferation p pr pro prol BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 - 1 11
a partial a a a a a BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 8 5 --, 3 11
needed to needed n ne nee need BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 -() 3 11
cells. IL-6 cells. c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 6 .-; 3 11
that IL-6 that t th tha that BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 7 -,- 3 11
[34, 35]. [34, [ [3 [34 [34, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 [,].- 5 11
receptor in receptor r re rec rece BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 [].,- 5 11
prostate cancer prostate p pr pro pros BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 9 -[, 3 11
38]. Thus, 38]. 3 38 38] 38]. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 ].,- 4 11
by not by b by by by BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 10 ,- 2 11
pre-osteoblast cell pre-osteoblast p pr pre pre- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 11 -. 2 11
Furthermore, it furthermore, F Fu Fur Furt BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 11 , 1 11
local RANKL/OPG local l lo loc loca BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 12 /'[]. 5 11
29 29 29 2 29 29 29 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 1 no 0 11
Thus DU145 thus T Th Thu Thus BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 1 - 1 11
tumoral bone tumoral t tu tum tumo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 1 , 1 11
the vicious the t th the the BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 2 (). 3 11
These findings these T Th The Thes BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 2 no 0 11
bone. Since bone. b bo bon bone BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 3 .""[], 6 11
unknown for unknown u un unk unkn BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 4 ., 2 11
been suggested been b be bee been BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 "" 2 11
environment. A environment. e en env envi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 . 1 11
with decreased/absent with w wi wit with BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 6 / 1 11
carcinoma [40]. carcinoma c ca car carc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 [].,- 5 11
preferentially attracted preferentially p pr pre pref BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 ,'' 3 11
factor that factor f fa fac fact BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 - 1 11
cells (osteoclast/osteoclast cells c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 (/)., 5 11
needed to needed n ne nee need BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 - 1 11
to bone to t to to to BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 . 1 11
In conclusion, in I In In In BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 11 ,- 2 11
interaction offer interaction i in int inte BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 11 , 1 11
by interfering by b by by by BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 12 -. 2 11
30 30 30 3 30 30 30 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 1 no 0 11
Acknowledgements Acknowledgements acknowledgements A Ac Ack Ackn BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 no 0 11
This work this T Th Thi This BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 , 1 11
West Committee west W We Wes West BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 9 7 . 1 11
from the from f fr fro from BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 . 1 11
31 31 31 3 31 31 31 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 1 no 0 11
References References references R Re Ref Refe BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 1 no 0 11
1. Landis 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 .,,,.,.; 8 11
49: 8-31. 49: 4 49 49: 49: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 :-. 3 11
2. Mundy 2. 2 2. 2. 2. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 ..:,. 5 11
Cancer 2002; cancer C Ca Can Canc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 ;:-. 4 11
3. Clarke 3. 3 3. 3. 3. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 4 .,,. 4 11
replacement in replacement r re rep repl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .;:-. 5 11
4. Garnero 4. 4 4. 4. 4. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 .,,,,,. 7 11
for the for f fo for for BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 .; 2 11
82: 858-64. 82: 8 82 82: 82: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 :-. 3 11
5. Inoue 5. 5 5. 5. 5. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 .,,,,,,,, 9 11
Shimizu K, shimizu S Sh Shi Shim BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 ,,,. 4 11
through two through t th thr thro BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 12 .;:-. 5 11
32 32 32 3 32 32 32 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 1 no 0 11
6. Zhang 6. 6 6. 6. 6. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 .,,,,,,,,, 10 11
ET. Osteoprotegerin et. E ET ET. ET. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 .- 2 11
tumor growth tumor t tu tum tumo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 3 .;:-. 5 11
7. Zhang 7. 7 7. 7. 7. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 3 .,,,,,. 7 11
factor κB factor f fa fac fact BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 .;:-. 5 11
8. Corey 8. 8 8. 8. 8. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 .,,,,,,. 8 11
in prostate in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 7 .;:-. 5 11
9. Whang 9. 9 9. 9. 9. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 8 .,,,,. 6 11
blockade and blockade b bl blo bloc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 no 0 11
bone. J bone. b bo bon bone BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 9 .;:-. 5 11
10. Théoleyre 10. 1 10 10. 10. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 .,,,,,. 7 11
OPG/RANK/RANKL: involvement opg/rank/rankl: O OP OPG OPG/ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 11 //: 3 11
remodeling. Cytokine remodeling. r re rem remo BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 12 .;:-. 5 11
33 33 33 3 33 33 33 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 1 no 0 11
11. Hofbauer 11. 1 11 11. 11. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 .,,.- 5 11
ligand and ligand l li lig liga BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 1 : 1 11
malignant bone malignant m ma mal mali BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 .;:-. 5 11
12. Kong 12. 1 12 12. 12. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 .,,,,,,, 8 11
Oliveira-dos-Santos AJ, oliveira-dos-santos O Ol Oli Oliv BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 3 --,,,,,,, 9 11
TW, Boyle tw, T TW TW, TW, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 4 ,,., 4 11
development and development d de dev deve BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 9 5 -.;:-. 6 11
13. Burgess 13. 1 13 13. 13. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 6 .,,,,,,,, 9 11
WJ, Dunstan wj, W WJ WJ, WJ, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 7 ,,,.() 6 11
mature osteoclasts. mature m ma mat matu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 .;:-. 5 11
14. Lacey 14. 1 14 14. 14. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 8 .,,,,,,,, 9 11
Elliott G, elliott E El Ell Elli BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 10 ,,,,,,,,, 9 11
Kaufman S, kaufman K Ka Kau Kauf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 9 11 ,,,,,,. 7 11
ligand is ligand l li lig liga BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 12 .;: 3 11
165-76. 165-76. 165-76. 1 16 165 165- BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 12 -. 2 11
34 34 34 3 34 34 34 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 1 no 0 11
15. Hsu 15. 1 15 15. 15. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 .,,,,,,,, 9 11
Kelley MJ, kelley K Ke Kel Kell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 2 ,,,,,,,,, 9 11
Morony S, morony M Mo Mor Moro BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 3 ,,,. 4 11
RANK mediates rank R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 10 4 . 1 11
Proc Natl proc P Pr Pro Proc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 ;:-. 4 11
16. Wittrant 16. 1 16 16. 16. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,,,. 8 11
RANKL/RANK/OPG: new rankl/rank/opg: R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 //:. 4 11
Biochimica Biophysica biochimica B Bi Bio Bioc BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 7 ;:-. 4 11
17. Brown 17. 1 17 17. 17. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .,,,,,,. 8 11
and rank and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 .;:-. 5 11
18. Brown 18. 1 18 18. 18. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 9 .,,,,,. 7 11
osteoprotegerin levels osteoprotegerin o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 10 . 1 11
2001; 7: 2001; 2 20 200 2001 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 10 ;:-. 4 11
19. Holen 19. 1 19 19. 19. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 11 .,,,.() 7 11
human prostate human h hu hum huma BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 12 .;:-. 5 11
35 35 35 3 35 35 35 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 1 no 0 11
20. Nakagawa 20. 2 20 20. 20. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 .,,,,,,, 8 11
Higashio K. higashio H Hi Hig Higa BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 2 . 1 11
osteoclastogenesis. Biochem osteoclastogenesis. o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 3 .;:-. 5 11
21. Wittrant 21. 2 21 21. 21. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 3 .,,,,,,. 8 11
directly induces directly d di dir dire BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 4 --- 3 11
osteosarcoma cells. osteosarcoma o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 .;:-. 5 11
22. Tometsko 22. 2 22 22. 22. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 6 .,,,,,,. 8 11
RANK Ligand rank R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 10 7 ,, 2 11
factors on factors f fa fac fact BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 8 ---. 4 11
2004; 19: 2004; 2 20 200 2004 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 9 ;:. 3 11
23. Chirgwin 23. 2 23 23. 23. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 9 .,.- 4 11
metastases. Crit metastases. m me met meta BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 10 .;:-. 5 11
24. Chirgwin 24. 2 24 24. 24. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 11 .,,.- 5 11
metastases. J metastases. m me met meta BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 12 .;:-. 5 11
36 36 36 3 36 36 36 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 1 no 0 11
25. Guise 25. 2 25 25. 25. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 .,.- 4 11
metastases. Clin metastases. m me met meta BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 2 .;():-. 7 11
26. Hansen 26. 2 26 26. 26. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 2 .,,.- 5 11
rapid dye rapid r ra rap rapi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 3 /.;:-. 6 11
27. Chipoy 27. 2 27 27. 27. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,,,,,,, 8 11
D, Blanchard d, D D, D, D, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 6 ,. 2 11
acidic protein acidic a ac aci acid BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 6 . 1 11
Miner Res miner M Mi Min Mine BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 10 7 ;:-. 4 11
28. Fisher 28. 2 28 28. 28. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 8 .,,,,,. 7 11
model of model m mo mod mode BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 .;:-. 5 11
29. Srivastava 29. 2 29 29. 29. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,,,,,,. 8 11
Receptor activator receptor R Re Rec Rece BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 11 - 1 11
cells. J cells. c ce cel cell BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 12 .;:-. 5 11
37 37 37 3 37 37 37 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 1 no 0 11
30. Jones 30. 3 30 30. 30. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 .,,,,,,, 8 11
Rubin E, rubin R Ru Rub Rubi BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 10 2 ,,,,,,,, 8 11
Khokha R, khokha K Kh Kho Khok BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 3 ,,. 3 11
RANKL. Nature rankl. R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 4 .;:-. 5 11
31. Lee 31. 3 31 31. 31. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 .,. 3 11
osteoclasts. Biochem osteoclasts. o os ost oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 6 .;:-. 5 11
32. Guise 32. 3 32 32. 32. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 ...; 4 11
2: 570-2. 2: 2 2: 2: 2: BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 8 :-. 3 11
33. Kim 33. 3 33 33. 33. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 8 .,,,.- 6 11
decreases osteoclastogenesis decreases d de dec decr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 9 .. 2 11
34. Kwan 34. 3 34 34. 34. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 .,,,,.-,, 9 11
TNF-alpha/IL-1: interrelations tnf-alpha/il-1: T TN TNF TNF- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 11 -/-:. 5 11
Rev 2004; rev R Re Rev Rev BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 12 ;:-. 4 11
38 38 38 3 38 38 38 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 1 no 0 11
35. Franchimont 35. 3 35 35. 35. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 .,,.-: 6 11
formation? Bone formation? f fo for form BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 2 ?;:-. 5 11
36. Mori 36. 3 36 36. 36. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 2 .,-,. 5 11
membrane and membrane m me mem memb BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 3 -. 2 11
1998; 18: 1998; 1 19 199 1998 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 4 ;:-. 4 11
37. Chung 37. 3 37 37. 37. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 .,,,,. 6 11
IL-6 in il-6 I IL IL- IL-6 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 6 -.;:-. 6 11
38. Smith 38. 3 38 38. 38. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 .,,,,.- 7 11
progression. Cytokine progression. p pr pro prog BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 .;:-. 5 11
39. Paget 39. 3 39 39. 39. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 9 ...;: 5 11
571-2. 571-2. 571-2. 5 57 571 571- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 10 -. 2 11
40. Bhatia 40. 4 40 40. 40. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 10 .,,. 4 11
factor-kappaB is factor-kappab f fa fac fact BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 11 -. 2 11
Cancer Res cancer C Ca Can Canc BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 12 ;:-. 4 11
39 39 39 3 39 39 39 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 1 no 0 11
Figure legends figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 1 no 0 11
Figure 1. figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 1 .,,- 4 11
LIF at lif L LI LIF LIF BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 2 .- 2 11
(RANKL), RANK, (rankl), ( (R (RA (RAN BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 2 (),,(),()-,-,() 15 11
leukemia inhibitory leukemia l le leu leuk BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 4 () 2 11
by semi-quantitative by b by by by BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 4 -- 2 11
Methods section. methods M Me Met Meth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 5 . 1 11
Figure 2. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 5 .. 2 11
Immunocytochemistry of immunocytochemistry I Im Imm Immu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 6 ()() 4 11
respective negative respective r re res resp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 7 (,).:. 6 11
Figure 3. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 .- 2 11
PC3 cells. pc3 P PC PC3 PC3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .-,, 4 11
then incubated then t th the then BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 9 / 1 11
RANKL. Aliquots rankl. R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 10 .- 2 11
1/2, p38 1/2, 1 1/ 1/2 1/2, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 11 /,-,, 5 11
section. (A) section. s se sec sect BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 12 .(),(). 7 11
40 40 40 4 40 40 40 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 1 no 0 11
Figure 4. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 1 ./.() 5 11
Treatment of treatment T Tr Tre Trea BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 1 (,,/) 5 11
cell invasion cell c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 2 -(-). 5 11
The effects the T Th The The BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 3 ()(: 4 11
ratio of ratio r ra rat rati BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 3 :)(,). 6 11
of signal of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 4 [,/ 3 11
(10µM); SB (10µm); ( (1 (10 (10µ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 ();,(),- 8 11
(18µM)]. Only (18µm)]. ( (1 (18 (18µ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 ()].- 5 11
migration (f, migration m mi mig migr BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 (,)./ 5 11
on the on o on on on BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 7 (,); 4 11
of DU145. of o of of of BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 7 .()-. 5 11
DU145 cell du145 D DU DU1 DU14 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 / 1 11
shRANKL by shrankl s sh shR shRA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 9 . 1 11
distinct sections distinct d di dis dist BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 9 .*.,-'. 7 11
Figure 5. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 10 .(). 4 11
precursors were precursors p pr pre prec BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 11
section. They section. s se sec sect BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 11 .( 2 11
10 6 10 1 10 10 10 BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 12 ) 1 11
41 41 41 4 41 41 41 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 1 no 0 11
different soluble different d di dif diff BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 1 (-/).*.( 8 11
without DU145 without w wi wit with BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 1 ),-'. 5 11
Figure 6. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 2 .- 2 11
MC3T3-E1 cell mc3t3-e1 M MC MC3 MC3T BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 2 -.()-- 6 11
for 72 for f fo for for BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 3 () 2 11
or absence or o or or or BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 4 / 1 11
section. Cell section. s se sec sect BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 5 ..*.( 5 11
DU145 cells du145 D DU DU1 DU14 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 5 ),-'.(), 8 11
factor blocker factor f fa fac fact BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 6 -. 2 11
**p<0.001 (CM **p<0.001 * ** **p **p< BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 7 **.(),-'.: 10 11
conditioned medium, conditioned c co con cond BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 8 ,:,:/,: 7 11
100µg/ml. (C) 100µg/ml. 1 10 100 100µ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 9 /.()--(/)- 10 11
(10µg/ml) were (10µg/ml) ( (1 (10 (10µ BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 10 (/).-- 6 11
receptor antibody receptor r re rec rece BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 11 ,-- 3 11
proliferation. †p=0.05 proliferation. p pr pro prol BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 11 ..(-- 5 11
CM from cm C CM CM CM BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 12 12 ),-'. 5 11
42 42 42 4 42 42 42 BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 12 1 no 0 11
Figure 7. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 1 .()-/ 5 11
phospho-STAT3 activation phospho-stat3 p ph pho phos BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 2 --.-,- 6 11
were washed were w we wer were BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 3 -, 2 11
incubated for incubated i in inc incu BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 4 ().- 4 11
then incubated then t th the then BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 4 ,,, 3 11
cells. After cells. c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 5 ., 2 11
section and section s se sec sect BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 6 . 1 11
Figure 8. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 7 . 1 11
cells and cells c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 7 /. 2 11
RANK-positive prostate rank-positive R RA RAN RANK BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 8 - 1 11
in RANKL. in i in in in BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 12 9 ., 2 11
cells has cells c ce cel cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 9 :/. 3 11
RANKL acts rankl R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 10 '' 2 11
activating both activating a ac act acti BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 11 -. 2 11
: RANKL, : : : : : BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 11 :, 2 2
: RANK, : : : : : BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 11 :, 2 2
: OPG, : : : : : BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 11 :,: 3 3
soluble factor(s) soluble s so sol solu BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 12 (). 3 11
Figure 1 figure F Fi Fig Figu BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 1 no 0 11
18S 18S 18s 1 18 18S 18S BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 2 no 0 8
RANK RANK rank R RA RAN RANK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 12 2 no 0 9
RANKL RANKL rankl R RA RAN RANK BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 2 no 0 11
OPG OPG opg O OP OPG OPG BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 2 no 0 8
PC3 PC3 pc3 P PC PC3 PC3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 5 no 0 11
DU145 DU145 du145 D DU DU1 DU14 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 6 no 0 11
LIF LIF lif L LI LIF LIF BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 6 no 0 8
OSM OSM osm O OS OSM OSM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 6 no 0 8
IL-11 IL-11 il-11 I IL IL- IL-1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 6 - 1 11
IL-6 IL-6 il-6 I IL IL- IL-6 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 6 - 1 9
DU145 DU145 du145 D DU DU1 DU14 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 11 no 0 11
PC3 PC3 pc3 P PC PC3 PC3 BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 12 no 0 11
Figure 2 figure F Fi Fig Figu BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 1 no 0 11
PC3 PC3 pc3 P PC PC3 PC3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 2 no 0 8
DU145 DU145 du145 D DU DU1 DU14 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 2 no 0 11
RANK RANK rank R RA RAN RANK BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 12 5 no 0 11
Control Control control C Co Con Cont BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 6 no 0 11
C C c C C C C BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 7 no 0 11
A A a A A A A BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 12 7 no 0 11
B B b B B B B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 10 no 0 11
D D d D D D D BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 10 no 0 11
Figure 3A figure F Fi Fig Figu BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 1 no 0 11
Phospho-INB Phospho-INB phospho-inb P Ph Pho Phos BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 1 - 1 11
Total-INB Total-INB total-inb T To Tot Tota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 1 - 1 9
Total-p38 Total-p38 total-p38 T To Tot Tota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 1 - 1 9
Phospho-p38 Phospho-p38 phospho-p38 P Ph Pho Phos BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 1 - 1 11
Phospho-ERK 1/2 phospho-erk P Ph Pho Phos BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 3 -/ 2 7
Total-ERK 1/2 total-erk T To Tot Tota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 3 -/ 2 6
0 2 0 0 0 0 0 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 12 3 no 0 11
Time (min.) time T Ti Tim Time BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 6 (.) 3 11
DU145 cells du145 D DU DU1 DU14 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 7 no 0 8
shRANKL 100ng/ml shrankl s sh shR shRA BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 7 / 1 11
Figure 3B figure F Fi Fig Figu BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 8 no 0 11
0 2 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 12 8 no 0 11
Time (min.) time T Ti Tim Time BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 9 (.) 3 11
PC3 cells pc3 P PC PC3 PC3 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 10 no 0 7
shRANKL 100ng/ml shrankl s sh shR shRA BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 10 / 1 11
Phospho-ERK 1/2 phospho-erk P Ph Pho Phos BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 11 -/ 2 11
Total-ERK 1/2 total-erk T To Tot Tota BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 11 -/ 2 9
Figure 4A figure F Fi Fig Figu BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 1 no 0 11
0H 0H 0h 0 0H 0H 0H BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 1 no 0 9
0H 0H 0h 0 0H 0H 0H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 1 no 0 9
24H 24H 24h 2 24 24H 24H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 1 no 0 11
shRANKL shRANKL shrankl s sh shR shRA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 2 no 0 11
0ng/ml 0ng/ml 0ng/ml 0 0n 0ng 0ng/ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 2 / 1 9
shRANKL shRANKL shrankl s sh shR shRA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 2 no 0 10
100ng/ml 100ng/ml 100ng/ml 1 10 100 100n BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 2 / 1 11
h h h h h h h BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 12 3 no 0 11
i i i i i i i BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 12 3 no 0 11
PC3 cells pc3 P PC PC3 PC3 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 4 no 0 11
shRANKL shRANKL shrankl s sh shR shRA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 4 no 0 11
0ng/ml 0ng/ml 0ng/ml 0 0n 0ng 0ng/ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 4 / 1 9
shRANKL shRANKL shrankl s sh shR shRA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 5 no 0 11
5ng/ml 5ng/ml 5ng/ml 5 5n 5ng 5ng/ BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 5 / 1 9
shRANKL shRANKL shrankl s sh shR shRA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 5 no 0 10
100ng/ml 100ng/ml 100ng/ml 1 10 100 100n BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 5 / 1 11
24H 24H 24h 2 24 24H 24H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 6 no 0 11
c c c c c c c BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 12 6 no 0 11
a a a a a a a BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 12 7 no 0 11
b b b b b b b BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 12 7 no 0 11
hOPG hOPG hopg h hO hOP hOPG BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 7 no 0 7
100ng/ml 100ng/ml 100ng/ml 1 10 100 100n BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 7 / 1 11
shRANKL 100ng/ml shrankl s sh shR shRA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 8 / 1 11
+UO126 10µM +uo126 + +U +UO +UO1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 8 no 0 8
shRANKL 50ng/ml shrankl s sh shR shRA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 9 / 1 11
+hOPG 250ng/ml +hopg + +h +hO +hOP BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 9 / 1 10
d d d d d d d BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 12 10 no 0 11
e e e e e e e BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 12 10 no 0 11
f f f f f f f BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 12 11 no 0 11
g g g g g g g BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 12 11 no 0 11
shRANKL 0ng/ml shrankl s sh shR shRA BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 11 / 1 11
+UO126 10µM +uo126 + +U +UO +UO1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 11 no 0 9
DU145 cells du145 D DU DU1 DU14 BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 12 no 0 11
0H 0H 0h 0 0H 0H 0H BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 1 no 0 11
24H 24H 24h 2 24 24H 24H BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 1 no 0 11
CT CT ct C CT CT CT BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 2 no 0 6
RANKL RANKL rankl R RA RAN RANK BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 2 no 0 11
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 12 3 no 0 7
0.6 0.6 0.6 0 0. 0.6 0.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 3 . 1 11
1.2 1.2 1.2 1 1. 1.2 1.2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 3 . 1 11
CT CT ct C CT CT CT BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 6 no 0 11
shRANKL shRANKL shrankl s sh shR shRA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 7 no 0 11
Invaded areas invaded I In Inv Inva BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 7 () 2 11
* * * * * * * BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 11 * 1 11
Figure 4B figure F Fi Fig Figu BLOCKSTART PAGEEND SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 12 no 0 11
Figure 5 figure F Fi Fig Figu BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 1 no 0 11
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 12 1 no 0 6
200 200 200 2 20 200 200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 12 1 no 0 9
400 400 400 4 40 400 400 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 12 1 no 0 9
600 600 600 6 60 600 600 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 12 1 no 0 9
800 800 800 8 80 800 800 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 12 1 no 0 9
1000 1000 1000 1 10 100 1000 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 12 1 no 0 11
1200 1200 1200 1 12 120 1200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 12 1 no 0 11
1400 1400 1400 1 14 140 1400 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 12 1 no 0 11
Osteoclasts Osteoclasts osteoclasts O Os Ost Oste BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 5 no 0 7
/ / / / / / / BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 5 / 1 2
well well well w we wel well BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 5 no 0 4
Direct co-culture direct D Di Dir Dire BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 5 - 1 11
* * * * * * * BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 8 * 1 2
Separate co-culture separate S Se Sep Sepa BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 8 - 1 11
** ** ** * ** ** ** BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 10 ** 2 11
DU145 DU145 du145 D DU DU1 DU14 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 10 no 0 11
- + - - - - - BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 11 - 1 11
+ + + + + + + BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 12 no 0 11
- - - - - - - BLOCKSTART PAGEEND NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 12 - 1 11
Figure 6 figure F Fi Fig Figu BLOCKSTART PAGESTART NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 1 no 0 11
B B b B B B B BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 1 no 0 11
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 12 1 no 0 11
4 4 4 4 4 4 4 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 12 1 no 0 11
CT CM ct C CT CT CT BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 1 no 0 9
CM CM cm C CM CM CM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 12 1 no 0 5
CM+S50 CM+S50 cm+s50 C CM CM+ CM+S BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 1 no 0 9
CM+S100 CM+S100 cm+s100 C CM CM+ CM+S BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 1 no 0 11
Days Days days D Da Day Days BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 1 no 0 7
1 1 1 1 1 1 1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 12 2 no 0 11
7 7 7 7 7 7 7 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 12 2 no 0 11
** ** ** * ** ** ** BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 2 ** 2 11
1.0 1.0 1.0 1 1. 1.0 1.0 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 2 . 1 11
0.6 0.6 0.6 0 0. 0.6 0.6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 2 . 1 11
0.4 0.4 0.4 0 0. 0.4 0.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 2 . 1 11
1.4 1.4 1.4 1 1. 1.4 1.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 2 . 1 11
0 0 0 0 0 0 0 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 12 2 no 0 7
Cell number cell C Ce Cel Cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 3 () 2 11
* * * * * * * BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 3 * 1 11
- - - - - - - BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 4 - 1 11
+ + + + + + + BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 4 no 0 11
+ + + + + + + BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 4 no 0 11
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 4 - 1 11
0,000 0,000 0,000 0 0, 0,0 0,00 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 12 4 , 1 11
0,200 0,200 0,200 0 0, 0,2 0,20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 12 4 , 1 11
0,400 0,400 0,400 0 0, 0,4 0,40 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 12 4 , 1 11
0,600 0,600 0,600 0 0, 0,6 0,60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 12 4 , 1 11
0,800 0,800 0,800 0 0, 0,8 0,80 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 12 4 , 1 11
1,000 1,000 1,000 1 1, 1,0 1,00 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 12 4 , 1 11
1,200 1,200 1,200 1 1, 1,2 1,20 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 12 4 , 1 11
OD 450 od O OD OD OD BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 6 no 0 11
CT CM ct C CT CT CT BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 6 no 0 11
CM CM cm C CM CM CM BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 12 6 no 0 5
(DU145) (DU145) (du145) ( (D (DU (DU1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 6 () 2 11
shRANKL shRANKL shrankl s sh shR shRA BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 6 no 0 8
(100ng/ml) (100ng/ml) (100ng/ml) ( (1 (10 (100 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 6 (/) 3 11
A A a A A A A BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 1 0 0 0 0 0 12 7 no 0 11
C C c C C C C BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 7 no 0 11
0.000 0.000 0.000 0 0. 0.0 0.00 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 7 . 1 11
0.200 0.200 0.200 0 0. 0.2 0.20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 7 . 1 9
0.400 0.400 0.400 0 0. 0.4 0.40 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 7 . 1 9
0.600 0.600 0.600 0 0. 0.6 0.60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 7 . 1 9
0.800 0.800 0.800 0 0. 0.8 0.80 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 7 . 1 9
1.000 1.000 1.000 1 1. 1.0 1.00 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 7 . 1 9
1.200 1.200 1.200 1 1. 1.2 1.20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 7 . 1 9
1.400 1.400 1.400 1 1. 1.4 1.40 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 7 . 1 9
CT CT ct C CT CT CT BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 9 no 0 11
CT CT ct C CT CT CT BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 9 no 0 11
CM CM cm C CM CM CM BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 12 9 no 0 11
CM CT cm C CM CM CM BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 12 9 no 0 11
IL-6R IL-6R il-6r I IL IL- IL-6 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 9 - 1 11
LIF LIF lif L LI LIF LIF BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 10 no 0 11
CM CM cm C CM CM CM BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 12 10 no 0 6
(DU145) (DU145) (du145) ( (D (DU (DU1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 10 () 2 11
CT CM ct C CT CT CT BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 10 no 0 11
† † † † † † † BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 10 no 0 11
- - - - - - - BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 10 - 1 11
+ + + + + + + BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 11 no 0 11
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 11 - 1 11
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 11 - 1 11
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 11 - 1 11
+ + + + + + + BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 11 no 0 11
Goat IgG goat G Go Goa Goat BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 11 no 0 11
IL-6R IL-6R il-6r I IL IL- IL-6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 11 - 1 7
LIF LIF lif L LI LIF LIF BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 12 11 no 0 5
- - - - - - - BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 12 - 1 11
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 12 - 1 11
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 12 - 1 11
+ + + + + + + BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 12 no 0 11
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 12 - 1 11
- - - - - - - BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 12 - 1 11
† † † † † † † BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 12 no 0 11
Figure 7 figure F Fi Fig Figu BLOCKSTART PAGESTART NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 1 no 0 11
0 0 0 0 0 0 0 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 12 1 no 0 11
2 2 2 2 2 2 2 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 12 2 no 0 11
5 5 5 5 5 5 5 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 12 2 no 0 11
10 10 10 1 10 10 10 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 12 3 no 0 11
15 15 15 1 15 15 15 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 12 3 no 0 11
30 30 30 3 30 30 30 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 12 4 no 0 11
Time (min.) time T Ti Tim Time BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 4 (.) 3 6
Phospho-STAT3 Phospho-STAT3 phospho-stat3 P Ph Pho Phos BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 4 - 1 7
Total-STAT3 Total-STAT3 total-stat3 T To Tot Tota BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 12 4 - 1 6
CM from cm C CM CM CM BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 1 0 0 0 0 0 12 4 no 0 11
Phospho-ERK 1/2 phospho-erk P Ph Pho Phos BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 9 -/ 2 11
Total-ERK 1/2 total-erk T To Tot Tota BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 9 -/ 2 9
Figure 8 figure F Fi Fig Figu BLOCKSTART PAGESTART SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 1 no 0 11
Osteoblastic Osteoblastic osteoblastic O Os Ost Oste BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 1 no 0 11
Stromal Cells stromal S St Str Stro BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 2 no 0 11
Active Active active A Ac Act Acti BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 2 no 0 4
Osteoclast Osteoclast osteoclast O Os Ost Oste BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 2 no 0 6
Bone microenvironment bone B Bo Bon Bone BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 12 2 no 0 11
Osteoclast Osteoclast osteoclast O Os Ost Oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 4 no 0 11
Precursor Precursor precursor P Pr Pre Prec BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 4 no 0 10
Tumor-supportive Tumor-supportive tumor-supportive T Tu Tum Tumo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 5 - 1 11
growth factors growth g gr gro grow BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 6 no 0 11
Tumor cell tumor T Tu Tum Tumo BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 12 7 no 0 11
migration migration migration m mi mig migr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 7 no 0 9
X X x X X X X BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 12 8 no 0 11
Pre-osteoblast cells pre-osteoblast P Pr Pre Pre- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 8 - 1 11
proliferation proliferation proliferation p pr pro prol BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 12 8 no 0 7
Prostate cancer prostate P Pr Pro Pros BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 10 no 0 11
Osteoblastic Osteoblastic osteoblastic O Os Ost Oste BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 11 no 0 11
Stromal Cells stromal S St Str Stro BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 12 11 no 0 11
osteoclastogenesis osteoclastogenesis osteoclastogenesis o os ost oste BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 12 12 no 0 11

